Transforming growth factor-beta 1 levels in women with prior history of gestational diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 76, Issue 2, 2007, Pages 193-198

  Yener, S ^a   Demir, T ^a   Akinci, B ^a   Bayraktar, F ^a   Kebapcilar, L ^a   Ozcan, M A ^a   Biberoglu, S ^a   Yesil, S ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Previous gestational diabetes mellitus; Transforming growth factor beta 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WAIST CIRCUMFERENCE;

ADULT; AGE FACTORS; BODY MASS INDEX; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; PREGNANCY; REGRESSION ANALYSIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33947127546     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.08.014     Document Type: Article

References (38)

1. Le Y., Yu X., Ruan L., Wang O., Qi D., Zhu J., et al. The immunopharmacological properties of transforming growth factor beta. Int Immunopharmacol 5 (2005) 1771-1782
2. Grainger D.J. Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arteriosc Thromb Vasc Biol 24 3 (2004) 399-404
3. Peterson M.C. Circulating transforming growth factor beta-1: a partial molecular explanation for associations between hypertension, diabetes, obesity, smoking and human disease involving fibrosis. Med Sci Monit 11 7 (2005) RA229-RA232
4. Laviades C., Varo N., and Diez J. Transforming growth factor beta in hypertensives with cardiorenal damage. Hypertension 36 4 (2000) 517-522
5. Romano M., Guagnano M.T., Pacini G., Vigneri S., Falco A., Marinopiccoli M., et al. Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab 88 (2003) 5321-5326
6. Porreca E., Di Febbo C., Vitacolonna E., Baccante G., Di Castelnuovo A., Angelini A., et al. Transforming growth factor-beta1 levels in hypertensive patients: association with body mass index and leptin. Am J Hypertens 15 (2002) 759-765
7. Pfeiffer A., Middelberg-Bisping K., Drewes C., Schatz H., et al. Elevated plasma levels of transforming growth factor-beta 1 in NIDDM. Diabet Care 19 (1996) 1113-1117
8. Esmatjes E., Flores L., Lario S., Claria J., Cases A., Inigo P., Campistol J.M., et al. Smoking increases serum levels of transforming growth factor-beta in diabetic patients. Diabet Care 22 (1999) 1915-1916
9. Shankland S.J., Scholey J.W., Ly H., and Thai K. Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy. Kidney Int 46 (1994) 430-442
10. Wang W., Koka V., and Lan H.Y. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 10 1 (2005) 48-56
11. Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor beta in human disease. N Engl J Med 342 18 (2000) 1350-1358
12. Kaufmann R.C., Schleyhahn F.T., Huffman D.G., and Amankwah K.S. Gestational diabetes diagnostic criteria: long-term maternal follow-up. Am J Obstet Gynecol 172 (1995) 621-625
13. Metzger B.E., Cho N.H., Roston S.M., and Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabet Care 16 (1993) 1598-1605
14. Heitritter S.M., Solomon C.G., Mitchell G.F., Skali-Ounis N., and Seely E.W. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 90 (2005) 3983-3988
15. Winzer C., Wagner O., Festa A., Schneider B., Roden M., Bancher-Todesca D., et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabet Care 27 (2004) 1721-1727
16. Lauenborg J., Mathiesen E., Hansen T., Glumer C., Jorgensen T., Borch-Johnsen K., et al. The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 90 (2005) 4004-4010
17. Kousta E., Lawrence N.J., Godsland I.F., Penny A., Anyaoku V., Millauer B.A., et al. Insulin resistance and beta-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol (Oxf) 59 (2003) 289-297
18. Samad F., Pandey M., and Loskutoff D.J. Tissue factor gene expression in the adipose tissues of obese mice. Proc Natl Acad Sci USA 95 13 (1998) 7591-7596
19. Alessi M.C., Bastelica D., Morange P., Berthet B., Leduc I., Verdier M., et al. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 49 (2000) 1374-1380
20. Gottschling-Zeller H., Birgel M., Rohrig K., and Hauner H. Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture. Metabolism 49 (2000) 666-671
21. Sawdey M.S., and Loskutoff D.J. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 88 4 (1991) 1346-1353
22. Ghosh J., Murphy M.O., Turner N., Khwaja N., Halka A., Kielty C.M., and Walker M.G. The role of transforming growth factor beta1 in the vascular system. Cardiovasc Pathol 14 1 (2005) 28-36
23. Kurihara H., Yoshizumi M., Sugiyama T., Takaku F., Yanagisawa M., Masaki T., et al. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 159 (1989) 1435-1440
24. Stewart D.J., Levy R.D., Cernacek P., and Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?. Ann Intern Med 114 (1991) 464-469
25. Border W.A., and Noble N.A. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 31 1 Pt 2 (1998) 181-188
26. Rossert J., Terraz-Durasnel C., and Brideau G. Growth factors, cytokines, and renal fibrosis during the course of diabetic nephropathy. Diabet Metab 26 Suppl 4 (2000) 16-24
27. Grant P.J. Inflammatory atherothrombotic aspects of type 2 diabetes. Curr Med Res Opin 21 Suppl 1 (2005) S5-S12
28. Letterio J.J., and Roberts A.B. Regulation of immune responses by TGF-beta. Annu Rev Immunol 16 (1998) 137-161
29. McCartney-Francis N.L., Frazier-Jessen M., and Wahl S.M. TGF-beta: a balancing act. Int Rev Immunol 16 5-6 (1998) 553-580
30. Suzumura A., Sawada M., Yamamoto H., and Marunouchi T. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 151 (1993) 2150-2158
31. Shrikant P., Lee S.J., Kalvakolanu I., Ransohoff R.M., and Benveniste E.N. Stimulus-specific inhibition of intracellular adhesion molecule-1 gene expression by TGF-beta. J Immunol 157 (1996) 892-900
32. Winkler M.K., and Beveniste E.N. Transforming growth factor-beta inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes. Glia 22 2 (1998) 171-179
33. Flores L., Naf S., Hernaez R., Conget I., Gomis R., and Esmatjes E. Transforming growth factor beta at clinical onset of Type 1 diabetes mellitus. A pilot study. Diabet Med 21 (2004) 818-822
34. Li Z., et al. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension 33 1 (1999) 116-123
35. Lakatta E.G. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part III. Cellular and molecular clues to heart and arterial aging. Circulation 107 3 (2003) 490-497
36. Wang M., and Lakatta E.G. Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging. Hypertension 39 4 (2002) 865-873
37. Wang M., Zhang J., Spinetti G., Jiang L.Q., Monticone R., Zhao D., et al. Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. Am J Pathol 167 (2005) 1429-1442
38. Yamamoto K., Takeshita K., Kojima T., Takamatsu J., and Saito H. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc Res 66 (2005) 276-285